Edmonton’s Delta Genomics has been sold to Neogen Corporation, an American company with locations in the U.S., Scotland, Brazil, and Australia.
“The biggest visible change will be the logo,” Michelle Miller, Delta’s CEO who is now general manager of Neogen Canada, said in an e-newsletter from Livestock Genetic. “Even though the testing will be done in Nebraska, the DNA extraction, sample storage and analysis will still be done in Edmonton so the interface with our clients remains the same.”
Delta Genomics will now focus on the use and application of genomic data to the Canadian livestock industry, as opposed to the generation of that data, Miller said in the e-newsletter.
Delta is a major supplier of genetic testing to Canada’s purebred beef associations, commercial beef cattle producers, and national genomics research community. The laboratory has been a significant, long-term customer of Neogen’s comprehensive suite of genomic products.
“We see this as a positive move, especially for producers and researchers,” Miller said in the e-newsletter. “They will be able to leverage Neogen’s buying power and economies of scale, so are likely to see prices drop.”
“The sale of the genomics laboratory to Neogen fulfils the vision of the founders of Delta Genomics to create a commercially viable business that will provide value to Canadian livestock producers for the long term,” Delta chair Graham Plastow said in a Neogen news release.
Along with its genetics operation, Michigan-based Neogen also has food safety and animal safety operations. The food safety division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases, and sanitation concerns. The animal safety division makes and distributes a variety of animal health-care products, including diagnostics, pharmaceuticals, veterinary instruments, wound care, and disinfectants.